PacBio Looks to Raise up to $200M in IPO; Reports $15M Order Backlog
August 24, 2010
PacBio Looks to Raise up to $200M in IPO; Reports $15M Order Backlog
The company disclosed in the filing that it has generated revenue of $1.2 million — all from government grants — for the first six months of 2010. As of June 30, it had a backlog of "firm" orders of approximately $15 million, and as of mid-August, it had shipped five early-access PacBio RS instruments.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pac Bio Launches Developer Network for Upcoming Single-Molecule Sequencer
July 9, 2010 / BioInform - Pocketing $68M, PacBio Remains on Track for Commercial Launch — and Possible IPO — in 2010
August 18, 2009 / In Sequence - PacBio Books 7 RS Systems in Q3, Delays Launch of C2 Chemistry, Launches 'Customer Advocacy' Group
November 1, 2011 / In Sequence - Launch of PacBio RS Drives Q2 Revenue, but Investors Raise Concerns Over Pace of Uptake
August 9, 2011 / In Sequence - Expression Analysis Starts Providing Sequencing Services on PacBio RS
June 7, 2011 / In Sequence